<DOC>
	<DOCNO>NCT00047112</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Giving combination chemotherapy radiation therapy surgery may shrink tumor remove surgery . It yet know surgery effective without radiation therapy chemotherapy treat esophageal cancer . PURPOSE : Randomized phase III trial compare effectiveness surgery without radiation therapy chemotherapy treat patient esophageal cancer .</brief_summary>
	<brief_title>Surgery With Without Radiation Therapy Chemotherapy Treating Patients With Esophageal Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Compare overall survival patient resectable thoracic esophageal cancer treat neoadjuvant radio-chemotherapy surgery versus surgery alone . - Compare disease-free survival patient treat regimen . - Compare surgical mortality morbidity patient treat regimen . - Compare resectability patient treat regimen . - Determine validation new prognostic factor survival patient and/or efficacy neoadjuvant treatment . OUTLINE : This randomize , open-label , multicenter study . Patients stratify accord histology ( epidermoid carcinoma v adenocarcinoma v undifferentiated carcinoma ) , stage ( I vs IIA v IIB ) , tumor location ( carina v carina ) , participate center . Patients randomize 1 2 treatment arm . - Arm I : Patients undergo radiotherapy daily 5 day week 5 week . Patients receive fluorouracil IV continuously day 1-4 29-32 cisplatin IV day 1 2 29 30 ( low dose day 1-5 29-33 ) . Within 4-8 week completion radio-chemotherapy , patient undergo surgical resection . - Arm II : Patients undergo surgical resection . Patients follow every 4 month 2 year , every 6 month 3 year , annually thereafter . PROJECTED ACCRUAL : A total 380 patient ( 190 per treatment arm ) accrue study within 3 year .</detailed_description>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis stage I II thoracic esophageal cancer Tumor great 3 cm invasion mediastinal structure without extension lymph node ( T12 , N01 , M0 ) OR Tumor great 3 cm invasion mediastinal structure adenopathy great 1 cm ( T3 , N0 , M0 ) Epidermoid carcinoma adenocarcinoma Previously untreated Deemed resectable curative intent No carcinoma situ No small cell anaplastic carcinoma ( i.e. , chromogranin negative ) No small cell neuroendocrine carcinoma ( i.e. , chromogranin positive ) No multifocal esophageal carcinoma ( i.e. , 2 distinct lesion 5 cm apart ) No involvement pharyngoesophageal junction first 4 cm esophagus ( i.e. , proximal edge tumor le 19 cm dental arch ) No evidence extension tracheobronchial tree endoscopy , ultrasound , CT scan ( simple compression allow ) No sign mediastinal involvement CT scan No palpable subclavicular lymph node involvement cytology needle aspiration No lymph node origin celiac great 1 cm CT scan Perigastric lymph node far celiac trunk deem resectable allow unless tumor 30 mm CT scan PATIENT CHARACTERISTICS : Age Under 75 Performance status WHO 01 Life expectancy Not specify Hematopoietic Granulocyte count least 1,500/mm^3 Platelet count least 100,000/mm^3 Hepatic SGOT/SGPT ratio great 1 Albumin least 35 g/L Total protein great 80 % No liver cirrhosis previous failure No ascites No jaundice No rupture varicose esophageal vein No presence varicose esophageal vein Renal Creatinine great 1.25 time normal Cardiovascular Arterial O_2 great 60 mm Hg Arterial CO_2 great 45 mm Hg No myocardial infarction within past 6 month No progressive coronary artery disease grade 2 great No recent leave ventricular failure No arterial disease stage IIIV Pulmonary FEV_1 great 1 L/sec Other Able receive either study treatment No recurrent paralysis No weight loss great 10 % baseline No prior concurrent malignancy except basal cell skin cancer carcinoma situ cervix Not pregnant Fertile patient must use effective contraception 3 month completion chemotherapy PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy Not specify Endocrine therapy Not specify Radiotherapy Not specify Surgery Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>adenocarcinoma esophagus</keyword>
	<keyword>squamous cell carcinoma esophagus</keyword>
	<keyword>stage I esophageal cancer</keyword>
	<keyword>stage II esophageal cancer</keyword>
</DOC>